| 标题 |
 Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet. Haematology 作者：Mateos MV; Paiva B; Cedena MT; Puig N; Sureda-Balari AM; et al 出版日期：2025/08/01 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
馆长
GingerF
敬老院1号
Nole
cdercder
豆腐kkkkk
max
安详从蕾
OK
嘉心糖
奔跑
无极微光
XX
skearthy
馨馨的科科
Freya1528
Logan
li
W sir
皖公网安备34019202002308
